The JAK2V617F mutation can occur in a hematopoietic stem cell that exhibits no proliferative advantage: a case of human allogeneic transplantation.
Van Pelt
Kristien
K
Nollet
Friedel
F
Selleslag
Dominik
D
Knoops
Laurent
L
Constantinescu
Stefan N
SN
Criel
Arnold
A
Billiet
Johan
J
D049109:Cell Proliferation; D005260:Female; D018380:Hematopoietic Stem Cell Transplantation; D006412:Hematopoietic Stem Cells; D006801:Humans; D053614:Janus Kinase 2 / Q000235:genetics*; D020125:Mutation, Missense; D009190:Myelodysplastic Syndromes / Q000628:therapy; D014184:Transplantation, Homologous
C507924:JAK2 protein, human; D053614:Janus Kinase 2